Effect of spa therapy on quality of life for psoriasis patients
Assessment at 4.5 Months of the Effect of a Dermatology-Oriented Spa Therapy on the Quality of Life of Patients With Psoriasis (BAREGES)
This study is testing whether a 3-week spa therapy can improve the quality of life for people with stable psoriasis over 4.5 months.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 70 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Thermes de Bareges Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 2 sites (Argenteuil and 1 other locations) |
| Trial ID | NCT06735911 on ClinicalTrials.gov |
What this trial studies
This study evaluates the impact of a dermatology-oriented spa therapy on the quality of life of patients suffering from psoriasis over a period of 4.5 months. It is a prospective, before/after cohort follow-up study conducted at a single center, where participants will undergo a 3-week spa treatment. The study aims to assess changes in quality of life through repeated measurements before and after the intervention. Eligible patients must have stable psoriasis and meet specific inclusion criteria.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with stable psoriasis and a Dermatology Life Quality Index (DLQI) score greater than 10.
Not a fit: Patients with contraindications to thermal treatment or those who have recently undergone similar spa therapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this therapy could significantly improve the quality of life for patients with psoriasis.
How similar studies have performed: While there is limited data on spa therapy specifically for psoriasis, similar interventions in dermatology have shown promising results in improving patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years Patient with psoriasis Stable treatment in the last 6 months. DLQI \> 10 Patient presenting an indication for thermal treatment focused on dermatology (possible dual orientation). Patient affiliated to the social security system or such a system Available for an 18-day spa treatment and a 9-month follow-up For women of childbearing age: effective contraception Patient information and informed consent signature Exclusion Criteria: Contraindication to thermal treatment (e.g., ongoing chemotherapy/radiotherapy, uncontrolled progressive neoplasia, progressive heart disease, etc., according to the investigator's assessment) Predictable intolerance to thermal treatments (intolerance to heat, baths, etc.) Patient who has already undergone a dermatology-oriented spa treatment within the current thermal season Subject already included in an interventional clinical research protocol Persons referred to in articles L1121-5 to L1121-8 of the "Code de la Santé Publique" (pregnant women, women in labour and parturient and nursing mothers, persons deprived of liberty by judicial or administrative decision, persons subject to a legal protection measure or not being able to verbally communicate their agreement, minor)
Where this trial is running
Argenteuil and 1 other locations
- Centre Hospitalier Victor Dupouy — Argenteuil, France (Recruiting)
- Cabinet Luz Saint Sauveur — Pierrefitte-Nestalas, France (Recruiting)
Study contacts
- Study coordinator: FUSTIER NF Nans
- Email: nans.fustier@univ-grenoble-alpes.fr
- Phone: 04 76 76 50 40
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.